These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21673363)

  • 1. Mechanisms of immunological tolerance to the antigens of the central nervous system. Skin-induced tolerance as a new therapeutic concept.
    Szczepanik M
    J Physiol Pharmacol; 2011 Apr; 62(2):159-65. PubMed ID: 21673363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation and regulation of CNS autoimmunity.
    Goverman J; Brabb T; Paez A; Harrington C; von Dassow P
    Crit Rev Immunol; 1997; 17(5-6):469-80. PubMed ID: 9419434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection from autoimmunity by DNA vaccination against T-cell receptor.
    Buch T; Waisman A
    Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
    Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
    J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune tolerance and control of CNS autoimmunity: from animal models to MS patients].
    Liblau R; Cassan C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S12-22. PubMed ID: 18087225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients.
    Cassan C; Liblau RS
    J Neurochem; 2007 Feb; 100(4):883-92. PubMed ID: 17181557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.
    Szczepanik M; Tutaj M; Bryniarski K; Dittel BN
    J Neuroimmunol; 2005 Jul; 164(1-2):105-14. PubMed ID: 15899524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and spectrum of autoimmunity.
    Perl A
    Methods Mol Biol; 2012; 900():1-9. PubMed ID: 22933062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
    Kumar V; Sercarz E
    J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell vaccination in experimental autoimmune encephalomyelitis: a mathematical model.
    Borghans JA; De Boer RJ; Sercarz E; Kumar V
    J Immunol; 1998 Aug; 161(3):1087-93. PubMed ID: 9686566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune processes resulting from perturbations of self-nonself recognition.
    Weigle WO
    Recomb DNA Tech Bull; 1981 Sep; 4(3):107-15. PubMed ID: 6169116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell tolerance and autoimmunity to systemic and tissue-restricted self-antigens.
    Lohr J; Knoechel B; Nagabhushanam V; Abbas AK
    Immunol Rev; 2005 Apr; 204():116-27. PubMed ID: 15790354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity as an immune defense against degenerative processes: a primary mathematical model illustrating the bright side of autoimmunity.
    Nevo U; Golding I; Neumann AU; Schwartz M; Akselrod S
    J Theor Biol; 2004 Apr; 227(4):583-92. PubMed ID: 15038992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to experimental autoimmune encephalomyelitis induced by neonatal tolerization to myelin basic protein: clonal elimination vs. regulation of autoaggressive lymphocytes.
    Qin YF; Sun DM; Goto M; Meyermann R; Wekerle H
    Eur J Immunol; 1989 Feb; 19(2):373-80. PubMed ID: 2467819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral tolerance: therapeutic implications for autoimmune diseases.
    Faria AM; Weiner HL
    Clin Dev Immunol; 2006; 13(2-4):143-57. PubMed ID: 17162357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of immunologic tolerance in dermatology].
    Steinbrink K; Knop J
    Hautarzt; 2003 Jan; 54(1):45-52. PubMed ID: 12567257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance in the control of experimental models of autoimmune disease.
    Staines NA; Harper N
    Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.